RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재후보

        Betamethasone to Prevent Symptomatic Hypocalcaemia and Other Complications after Total Thyroidectomy: a Case-control Study

        Marcello Picchio,Annalisa Romina Di Filippo,Martina Spaziani,Simone Orelli,Riccardo Bellagamba,Giuliano Guttoriello,Alessandro De Cesare,Erasmo Spaziani 대한갑상선-내분비외과학회 2021 The Koreran journal of Endocrine Surgery Vol.21 No.3

        Purpose: The study aims to determine whether postoperative infusion of betamethasone reduces the risk of symptomatic hypocalcaemia (SHC) and other complications after total thyroidectomy. Methods: We compared a group of patients receiving betamethasone (beta group) postoperatively to a group without any perioperative glucocorticoid infusion (no beta group). Plasma levels of parathyroid hormone, total calcium, and C-reactive protein (CRP) were measured pre- and postoperatively. Complications were recorded within a 30-day follow-up. Postoperative SHC was the primary outcome. Results: In the beta group and the no beta group, 54 patients and 47 patients were included, respectively. In the beta group, the incidence of SHC (4 pts vs. 14 pts in the no beta group; P=0.003) was reduced. In the beta group, serum calcium levels were higher on postoperative day 1 (8.6 mg/dL vs. 8.2 mg/dL in the no beta group; P=0.001) and day 2 (8.7 mg/dL vs. 8.1 mg/dL in the no beta group; P<0.000). In the beta group, serum C-reactive protein levels were lower postoperatively. In a univariate analysis, American Society of Anaesthesiology score > I (odds ratio [OR], 0.19; P=0.002), no betamethasone treatment (OR, 0.19; P=0.006), and parathyroid glands remaining in situ (PGRIS) score <3 (OR, 6.00; P=0.005) were related to postoperative SHC; in a multivariate analysis, betamethasone treatment (OR, 0.09; P=0.007) and PGRIS score <3 (OR, 8.41; P=0.045) were related to postoperative SHC. No difference was observed in postoperative complications. Conclusion: Postoperative use of betamethasone reduces the incidence of SHC after thyroid surgery without affecting other complications.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼